Global Organ-On-Chip Market Growth 2023-2029

Global Organ-On-Chip Market Growth 2023-2029

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
LPI (LP Information)' newest research report, the “Organ-On-Chip Industry Forecast” looks at past sales and reviews total world Organ-On-Chip sales in 2022, providing a comprehensive analysis by region and market sector of projected Organ-On-Chip sales for 2023 through 2029. With Organ-On-Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ-On-Chip industry.
This Insight Report provides a comprehensive analysis of the global Organ-On-Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Organ-On-Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Organ-On-Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ-On-Chip and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ-On-Chip.
The global Organ-On-Chip market size is projected to grow from US$ 59 million in 2022 to US$ 464.4 million in 2029; it is expected to grow at a CAGR of 464.4 from 2023 to 2029.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ-On-Chip market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Others
Segmentation by application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emulate
Mimetas
TissUse
Tara Biosystems
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
Beijing Daxiang Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Organ-On-Chip market?
What factors are driving Organ-On-Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Organ-On-Chip market opportunities vary by end market size?
How does Organ-On-Chip break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.